85 related articles for article (PubMed ID: 2660681)
1. Physicochemical aspects of heparin cofactor II.
Pratt CW; Whinna HC; Meade JB; Treanor RE; Church FC
Ann N Y Acad Sci; 1989; 556():104-15. PubMed ID: 2660681
[No Abstract] [Full Text] [Related]
2. [The second cofactor of heparin].
Sie P
Ann Biol Clin (Paris); 1987; 45(2):181-3. PubMed ID: 3619144
[TBL] [Abstract][Full Text] [Related]
3. Heparin cofactor II and other coagulation inhibitors.
Duckert F
Behring Inst Mitt; 1986 Feb; (79):9-11. PubMed ID: 3755039
[TBL] [Abstract][Full Text] [Related]
4. [The other heparin cofactor].
Sie P; Boneu B
Presse Med; 1987 Feb; 16(4):149-50. PubMed ID: 2950443
[No Abstract] [Full Text] [Related]
5. [Constitutional dysfunction of heparin cofactor II with a tendency for venous thrombosis].
Marbet GA; Zbinden B; Duckert F
Schweiz Med Wochenschr; 1988 Oct; 118(43):1586-8. PubMed ID: 3238395
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitors of the serine-proteases of coagulation with special reference to antithrombin III and heparin cofactor II].
Fontcuberta J
Sangre (Barc); 1985; 30(4-C):787-91. PubMed ID: 3841417
[No Abstract] [Full Text] [Related]
7. Inhibition of chymotrypsin by heparin cofactor II.
Church FC; Noyes CM; Griffith MJ
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6431-4. PubMed ID: 3863104
[TBL] [Abstract][Full Text] [Related]
8. [Antithrombin III and heparin cofactor II].
Kondo S; Niwa M
Rinsho Byori; 1985 Feb; Spec No 61():106-13. PubMed ID: 3839027
[No Abstract] [Full Text] [Related]
9. Carboxylate polyanions accelerate inhibition of thrombin by heparin cofactor II.
Church FC; Treanor RE; Sherrill GB; Whinna HC
Biochem Biophys Res Commun; 1987 Oct; 148(1):362-8. PubMed ID: 3675584
[TBL] [Abstract][Full Text] [Related]
10. Heparin cofactor II activation by dermatan sulfate.
Tollefsen DM; Maimone MM; McGuire EA; Peacock ME
Ann N Y Acad Sci; 1989; 556():116-22. PubMed ID: 2660682
[No Abstract] [Full Text] [Related]
11. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
Hortin GL; Tollefsen DM; Santoro SA
Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
[TBL] [Abstract][Full Text] [Related]
12. Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thrombin-heparin cofactor II complex.
Preissner KT; Sié P
Thromb Haemost; 1988 Dec; 60(3):399-406. PubMed ID: 2976993
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II.
Hurst RE; Poon MC; Griffith MJ
J Clin Invest; 1983 Sep; 72(3):1042-5. PubMed ID: 6688430
[TBL] [Abstract][Full Text] [Related]
14. Activation of heparin cofactor II by heparin and dermatan sulfate.
Tollefsen DM
Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014
[TBL] [Abstract][Full Text] [Related]
15. Methodology and clinical significance of heparin cofactor II. Probable heparin cofactor II deficiency in a patient with cerebrovascular thrombosis.
Tran TH; Zbinden B; Lämmle B; Duckert F
Semin Thromb Hemost; 1985 Oct; 11(4):342-6. PubMed ID: 3840916
[TBL] [Abstract][Full Text] [Related]
16. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
[TBL] [Abstract][Full Text] [Related]
17. Activation of heparin cofactor II by heparin oligosaccharides.
Maimone MM; Tollefsen DM
Biochem Biophys Res Commun; 1988 May; 152(3):1056-61. PubMed ID: 3377765
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of heparin cofactor II].
Takahashi K; Yamagishi R; Niwa M; Sakuragawa N
Rinsho Byori; 1987 Apr; Spec No 70():181-6. PubMed ID: 3302388
[No Abstract] [Full Text] [Related]
19. Laboratory diagnosis of antithrombin and heparin cofactor II deficiency.
Tollefsen DM
Semin Thromb Hemost; 1990 Apr; 16(2):162-8. PubMed ID: 2191430
[TBL] [Abstract][Full Text] [Related]
20. Effects of fibroblasts and endothelial cells on inactivation of target proteases by protease nexin-1, heparin cofactor II, and C1-inhibitor.
Hiramoto SA; Cunningham DD
J Cell Biochem; 1988 Mar; 36(3):199-207. PubMed ID: 3379101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
